The PwC report recorded commentary from health plan actuaries, industry leaders, employers and numerous other healthcare reports and surveys. Historically, the medical cost growth has been in the double digits, but since 2009, growth has slowed considerably.
PwC analysts said as patients become more cost-conscious healthcare consumers and healthcare providers and drug manufacturers place a bigger emphasis on value over volume, the mild increases in healthcare spending growth could become indicative of a broader economic shift. “If the structural forces in the industry take hold, the U.S. health system may be entering a ‘new normal,'” the report said.
Four main forces, which PwC analysts called “deflators,” could continue to slow the medical cost trend in 2013:
• Medical supply and equipment costs will decline under market pressure.
• New delivery methods of primary care, such as retail health clinics and telemedicine, will become more popular.
• Price transparency will exert pressure to lower hospital and healthcare prices.
• The “pharmaceutical patent cliff” will increase the use of lower-cost generic drugs.
Two factors that will inflate the medical cost trend in 2013 include an uptick in utilization and medical and technological advances.
More Articles on Healthcare Costs:
Report: High Prices at Hospitals, Others Drove High Healthcare Costs During Recession
Single-Payor Healthcare: What Could it Do on the National Stage?
U.S. Outspends 12 Industrialized Nations on Healthcare, But Quality Lags
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
